Serum 1,5-anhydroglucitol concentrations are a reliable index of glycemic control in type 2 diabetes with mild or moderate renal dysfunction

Diabetes Care

Volumn 35, Issue 2, 2012, Pages 281-286

  Kim, Won Jun ^a   Rhee, Eun Jung ^a   Park, Cheol Young ^a   Lee, Won Young ^a   Lee, Kyu Beck ^a   Oh, Ki Won ^a   Park, Se Eun ^a   Park, Sung Woo ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

1,5 ANHYDROSORBITOL; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN;

ADULT; AGE; AGED; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DIET THERAPY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE MARKER; DISEASE SEVERITY; DRUG USE; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RELIABILITY;

BLOOD GLUCOSE; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; DEOXYGLUCOSE; DIABETES MELLITUS, TYPE 2; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY DISEASES;

EID: 84859095662     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc11-1462     Document Type: Article

References (27)

1. Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of amultifactorial intervention on mortality in type 2 diabetes. N Engl J Med 2008;358:580-591 (Pubitemid 351214285)
2. Hovind P, Rossing P, Tarnow L, Smidt UM, Parving HH. Progression of diabetic nephropathy. Kidney Int 2001;59:702-709
3. Gilbert RE, Tsalamandris C, Bach LA, et al. Long-term glycemic control and the rate of progression of early diabetic kidney disease. Kidney Int 1993;44:855-859 (Pubitemid 23290529)
4. Hasslacher C, Bostedt-Kiesel A, Kempe HP, Wahl P. Effect of metabolic factors and blood pressure on kidney function in proteinuric type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1993;36: 1051-1056 (Pubitemid 23288775)
5. Yamanouchi T, Ogata N, Tagaya T, et al. Clinical usefulness of serum 1,5- anhydroglucitol in monitoring glycaemic control. Lancet 1996;347:1514-1518 (Pubitemid 26162642)
6. Dungan KM, Buse JB, Largay J, et al. 1,5- anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes. Diabetes Care 2006; 29:1214-1219 (Pubitemid 44125912)
7. Dungan KM. 1,5-anhydroglucitol (Glyco- Mark) asa marker of short-term glycemic control and glycemic excursions. Expert Rev Mol Diagn 2008;8:9-19
8. Akanuma Y, Morita M, Fukuzawa N, Yamanouchi T, Akanuma H. Urinary excretion of1,5-anhydro-D-glucitol accompanying glucose excretion in diabetic patients. Diabetologia 1988;31:831-835 (Pubitemid 19004935)
9. Yamanouchi T, Minoda S, Yabuuchi M, et al. Plasma 1,5-anhydro-D-glucitol asnew clinical marker of glycemic control in NIDDM patients. Diabetes 1989;38:723-729 (Pubitemid 19285725)
10. Yamanouchi T, Akanuma Y, Toyota T, et al. Comparison of1,5- anhydroglucitol, HbA1c, and fructosamine for detection of diabetes mellitus. Diabetes 1991;40:52-57
11. Tam WH, Rogers MS, Lau TK, Arumanayagam M. The predictive value of serum 1,5- anhydro-D-glucitol in pregnancies at increased risk of gestational diabetes mellitus and gestational impaired glucose tolerance. BJOG 2001;108:754-756 (Pubitemid 32778285)
12. Kilpatrick ES, Keevilt BG, Richmond KL, Newland P, Addison GM. Plasma 1,5- anhydroglucitol concentrations are influenced by variations in the renal threshold for glucose. Diabet Med 1999;16:496-499
13. Fujisawa T, Ikegami H, Tsutsui T, et al. Renal tubular function affects glycosuria-related urinary excretion of 1,5-anhydroglucitol. Diabetes Care 1999;22:863-864 (Pubitemid 29220803)
14. Emoto M, Tabata T, Inoue T, Nishizawa Y, Morii H. Plasma 1,5-anhydroglucitol concentration inpatients with end-stage renal disease with and without diabetes mellitus. Nephron 1992;61:181-186
15. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39(Suppl. 1):S1-S266
16. Won JC, Park CY, Park HS, et al. 1,5- Anhydroglucitol reflects postprandial hyperglycemia and a decreased insulinogenic index, even in subjects with prediabetes and well-controlled type 2 diabetes. Diabetes Res Clin Pract 2009; 84:51-57
17. Kishimoto M, Yamasaki Y, Kubota M, et al. 1,5-Anhydro-D-glucitol evaluates daily glycemic excursions in well-controlled NIDDM. Diabetes Care 1995;18:1156-1159
18. Stettler C, Stahl M, Allemann S, et al. Association of1,5-anhydroglucitol and 2-h postprandial blood glucose in type 2 diabetic patients. Diabetes Care 2008;31: 1534-1535
19. Shimizu H, Shouzu A, Nishikawa M, et al. Serum concentration and renal handling of 1,5-anhydro-D-glucitol in patients with chronic renal failure. Ann Clin Biochem 1999;36:749-754 (Pubitemid 29520975)
20. Niwa T, Dewald L, Sone J, Miyazaki T, Kajita M. Quantification of serum 1,5-anhydroglucitol in uremic and diabetic patients by liquid chromatography/mass spectrometry. Clin Chem 1994;40:260-264 (Pubitemid 24072585)
21. Yamada H, Hishida A, Kato A, Yoneyama T. 1,5-anhydroglucitol as amarker for the differential diagnosis of acute and chronic renal failure. Nephron 1996;73:707-709 (Pubitemid 26258214)
22. Yamanouchi T, Akanuma H, Nakamura T, Akaoka I, Akanuma Y. Reduction of plasma 1,5-anhydroglucitol (1-deoxyglucose) concentration in diabetic patients. Diabetologia 1988;31:41-45 (Pubitemid 18077571)
23. Ichikawa H, Nagake Y, Takahashi M, et al. What is the best index of glycemic control in patients with diabetes mellitus on hemodialysis? Nippon Jinzo Gakkai Shi 1996;38:305-308 (Pubitemid 126496398)
24. Yamanouchi T, Shinohara T, Ogata N, Tachibana Y, Akaoka I, Miyashita H. Common reabsorption system of1,5- anhydro-D-glucitol, fructose, and mannose in rat renal tubule. Biochim Biophys Acta 1996;1291:89-95 (Pubitemid 26284330)
25. Tazawa S, Yamato T, Fujikura H, et al. SLC5A9/SGLT4, anew Na+-dependent glucose transporter, is an essential transporter for mannose, 1,5-anhydro-D-glucitol, and fructose. Life Sci 2005;76:1039-1050 (Pubitemid 39643403)
26. Nakamura N, Masuda S, Takahashi K, Saito H, Okuda M, Inui K. Decreased expression of glucose and peptide transporters in rat remnant kidney. Drug Metab Pharmacokinet 2004;19:41-47
27. Medow MS, Reynolds R, Bovee KC, Segal S. Proline and glucose transport by renal membranes from dogs with spontaneous idiopathic Fanconi syndrome. Proc Natl Acad Sci USA 1981;78:7769-7772 (Pubitemid 12186644)